BioCentury | May 6, 2013
Regulation

The patient voice

...with CFS in 1996 after a tropical illness, said "particularly helpful" treatments included Valtrex valacyclovir, famciclovir...
...is a viral polymerase inhibitor marketed by GlaxoSmithKline plc to treat cytomegalovirus (CMV) infection. Famvir famciclovir...
BioCentury | Feb 13, 2012
Clinical News

Famvir famciclovir regulatory update

...Asahi Kasei submitted a regulatory application in Japan to expand the label of Famvir famciclovir to...
...Asahi Kasei Pharma Corp. , Tokyo, Japan Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Product: Famvir famciclovir...
BioCentury | Feb 22, 2010
Company News

Teva, Novartis infectious news

...herpes drug Famvir famciclovir. Novartis also is eligible for royalties on U.S. sales of generic famciclovir...
BioCentury | May 25, 2009
Product Development

Shackling shingle's pain

...inhibitors most commonly used to treat shingles are Valtrex valacyclovir from GlaxoSmithKline plc ; Famvir famciclovir...
BioCentury | Sep 25, 2008
Distillery Therapeutics

This Week in Therapeutics

...Zovirax acyclovir, two nucleoside analogs from GlaxoSmithKline plc, are marketed to treat HSV infection. Famvir famciclovir...
BioCentury | Oct 9, 2006
Company News

Tap Pharmaceutical, Novartis sales and marketing update

...The companies will co-promote NVS's herpes drug Famvir famciclovir in the U.S. Tap will be responsible...
BioCentury | Aug 7, 2006
Clinical News

Famvir famciclovir regulatory update

...mucocutaneous herpes simplex infections in HIV-infected patients. Novartis AG (NVS; SWX:NOVN), Basel, Switzerland Product: Famvir famciclovir...
BioCentury | Jan 2, 2006
Clinical News

Famvir famciclovir infectious data

...Antimicrobial Agents and Chemotherapy meeting in Washington. Novartis AG (NVS; SWX:NOVN), Basel, Switzerland Product: Famvir famciclovir...
BioCentury | Jul 30, 2001
Clinical News

Zadaxin synthetic thymosin alpha 1 regulatory update

...of allowance for a U.S. patent covering the use of its Zadaxin plus lamivudine and famciclovir...
BioCentury | Sep 5, 2000
Company News

Novartis, SmithKline deal

...NOVN will acquire from SB rights to Famvir famciclovir and Vectavir/Denavir penciclovir for $1.6 billion in...
Items per page:
1 - 10 of 18